{"id":83269,"date":"2026-07-30T00:05:44","date_gmt":"2026-07-30T00:05:44","guid":{"rendered":"https:\/\/english.saigonbiz.com\/vn\/onco360-has-been-selected-as-a-national-pharmacy-partner-for-veppanu-vepdegestrant\/"},"modified":"2026-07-30T00:05:44","modified_gmt":"2026-07-30T00:05:44","slug":"onco360-has-been-selected-as-a-national-pharmacy-partner-for-veppanu-vepdegestrant","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/onco360-has-been-selected-as-a-national-pharmacy-partner-for-veppanu-vepdegestrant\/","title":{"rendered":"Onco360\u00ae Has Been Selected as a National Pharmacy Partner for VEPPANU&#x2122; (vepdegestrant)"},"content":{"rendered":"<div>\n<p>LOUISVILLE, Ky., July  29, 2026  (GLOBE NEWSWIRE) &#8212; Onco360<sup>\u00ae<\/sup>, the nation\u2019s leading independent Specialty Pharmacy, has been selected as a pharmacy partner by Rigel Pharmaceuticals for VEPPANU&#x2122; (vepdegestrant), which is indicated for the treatment of adults with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative, <em>estrogen receptor-1<\/em> (<em>ESR1<\/em>)-mutated advanced or metastatic breast cancer, as detected by an FDA-authorized test, with disease progression following at least one line of endocrine therapy.<sup>1<\/sup> \u00a0<\/p>\n<p>\u201cWe are thrilled to continue our partnership with Rigel Pharmaceuticals to expand treatment options for patients living with breast cancer,\u201d said Benito Fernandez, Chief Commercial Officer. \u201cOur partnerships allow us to accelerate patient access to new therapies while delivering personalized clinical support and compassionate care throughout every stage of the patient journey.\u201d<\/p>\n<p>VEPPANU is an FDA-approved PROteolysis TArgeting Chimera (PROTAC), part of a new class of heterobifunctional protein degraders that bind to the estrogen receptor (ER) and E3 ligase cereblon (CRBN). This interaction results in a degradation cascade through CRBN-mediated polyubiquitination and proteasomal degradation of the ER, leading to a reduction in ER protein levels in breast cancer cells.<\/p>\n<p>VEPPANU\u2019s FDA approval was based on the Phase 3 VERITAC-2 clinical trial (NCT05654623), a global, randomized, open-label, pivotal clinical trial evaluating vepdegestrant versus fulvestrant in patients with ER-positive, HER-2-negative advanced or metastatic breast cancer<sup>2<\/sup>. In the trial, among patients with an <em>ESR1<\/em> mutation, vepdegestrant demonstrated a statistically significant and clinically meaningful improvement in progression-free survival (PFS), reducing the risk of disease progression or death by 43% compared to fulvestrant. The most common (\u226510%) adverse reactions, including laboratory abnormalities, were decreased white blood cells, increased AST, musculoskeletal pain, fatigue, decreased hemoglobin, decreased neutrophils, increased ALT, increased alkaline phosphatase, nausea, decreased blood potassium, increased bilirubin, decreased appetite, electrocardiogram QT prolongation, decreased platelets, and constipation<sup>1<\/sup>.<\/p>\n<p>Please read the full <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-f11AcrO5YGZAdk5_SyHt2kvqYCYR5qTPUUE8DNJftTGlVG-VCT60LFwxq_LxChCXBk_O-OLqwKz4yJJo7-vsH5bp7eSp3HUHNtYgAtREgeEiKFCzEBZcVMtGtxlFADj1RkKo1lb3PSPnHFbM1Z1biu3ioDvPGG04HVULmY3zf44xBpavPRJ4DyScG4Nem7m\" rel=\"nofollow\" target=\"_blank\" title=\"prescribing information\">prescribing information<\/a> for VEPPANU.<\/p>\n<p><strong>About Onco360 Oncology Pharmacy<\/strong><br \/>Onco360 is the nation\u2019s largest independent Oncology Pharmacy and clinical support services company. Onco360 was founded in 2003 to bring together the stakeholders involved in the cancer treatment process and serve the specialized needs of oncologists, patients, hospitals, cancer centers of excellence, manufacturers, health plans, and payers. It dispenses nationally through its network of URAC-, and ACHC-accredited Oncology Pharmacies. Onco360 is headquartered in Louisville, Kentucky, and is a flagship specialty pharmacy brand of PharMerica Corporation, a leading institutional pharmacy, specialty infusion, and hospital services company servicing healthcare facilities in the United States. For more information about Onco360, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0EEf9xtmuom7jeby_XVMiH7ojHwLis9GTTiEFn7mV-6RuLNyrO5hFkvq1P96h8AzuxuVvnNXl4eBjHQ1s0IH3Q==\" rel=\"nofollow\" target=\"_blank\" title=\"Onco360.com\">Onco360.com<\/a>.<\/p>\n<p>Media Contact: Benito Fernandez, Chief Commercial Officer<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3NxbQaDuTLh9G1cPT_2pr6JdGpmSLOMgJP3eguF1BMP1E5npYCek7yQCdzzAPfC06iM65BBtMxnwHK-R4Lj4c8hJp0ODxw_UFkDgIaDSf1oSnxDzI2aL-1Ez15XbfDWq\" rel=\"nofollow\" target=\"_blank\" title=\"Benito.fernandez@onco360.com\">Benito.fernandez@onco360.com<\/a><br \/>516-640-1332<\/p>\n<p><strong>References:\u00a0<\/strong><\/p>\n<p><sup>1<\/sup>Veppanu&#x2122; (vepdegestrant) [Package Insert]. Rigel Pharmaceuticals, Inc., South San Francisco, CA 94080\u00a0<\/p>\n<p><sup>2<\/sup>Hamilton, E.et.al. (2024). Vepdegestrant, a PROTAC estrogen receptor (ER) degrader, vs fulvestrant in ER-positive\/human epidermal growth factor receptor 2 (HER2)\u2013negative advanced breast cancer: Results of the global, randomized, phase 3 VERITAC-2 study.\u00a0<br \/><em>J Clin Oncol<\/em>\u00a043,\u00a0LBA1000-LBA1000(2025). DOI:10.1200\/JCO.2025.43.17_suppl.LBA1000<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MGU5OTNiZWItZDkyZC00ZGI1LWIxNTItYzVmNTNiMWY0MTg0LTUwMDEyMjkzNy0yMDI2LTA3LTI5LWVu\/tiny\/Onco360-Oncology-Pharmacy.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>LOUISVILLE, Ky., July 29, 2026 (GLOBE NEWSWIRE) &#8212; Onco360\u00ae, the nation\u2019s leading independent Specialty Pharmacy, has been selected as a pharmacy partner by Rigel Pharmaceuticals for VEPPANU&#x2122; (vepdegestrant), which is indicated for the treatment of adults with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative, estrogen receptor-1 (ESR1)-mutated advanced or metastatic breast cancer, [&#8230;]\n","protected":false},"author":1,"featured_media":85254,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"class_list":["post-83269","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-people"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Onco360\u00ae Has Been Selected as a National Pharmacy Partner for VEPPANU&#x2122; (vepdegestrant) - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/onco360-has-been-selected-as-a-national-pharmacy-partner-for-veppanu-vepdegestrant\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Onco360\u00ae Has Been Selected as a National Pharmacy Partner for VEPPANU&#x2122; (vepdegestrant)\" \/>\n<meta property=\"og:description\" content=\"LOUISVILLE, Ky., July 29, 2026 (GLOBE NEWSWIRE) &#8212; Onco360\u00ae, the nation\u2019s leading independent Specialty Pharmacy, has been selected as a pharm\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/onco360-has-been-selected-as-a-national-pharmacy-partner-for-veppanu-vepdegestrant\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-30T00:05:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/05\/SaigonBiz-Feature-Image.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1074\" \/>\n\t<meta property=\"og:image:height\" content=\"716\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/onco360-has-been-selected-as-a-national-pharmacy-partner-for-veppanu-vepdegestrant\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/onco360-has-been-selected-as-a-national-pharmacy-partner-for-veppanu-vepdegestrant\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"Onco360\u00ae Has Been Selected as a National Pharmacy Partner for VEPPANU&#x2122; (vepdegestrant)\",\"datePublished\":\"2026-07-30T00:05:44+00:00\",\"dateModified\":\"2026-07-30T00:05:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/onco360-has-been-selected-as-a-national-pharmacy-partner-for-veppanu-vepdegestrant\/\"},\"wordCount\":488,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"People\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/onco360-has-been-selected-as-a-national-pharmacy-partner-for-veppanu-vepdegestrant\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/onco360-has-been-selected-as-a-national-pharmacy-partner-for-veppanu-vepdegestrant\/\",\"name\":\"Onco360\u00ae Has Been Selected as a National Pharmacy Partner for VEPPANU&#x2122; (vepdegestrant) - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2026-07-30T00:05:44+00:00\",\"dateModified\":\"2026-07-30T00:05:44+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/onco360-has-been-selected-as-a-national-pharmacy-partner-for-veppanu-vepdegestrant\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/onco360-has-been-selected-as-a-national-pharmacy-partner-for-veppanu-vepdegestrant\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/onco360-has-been-selected-as-a-national-pharmacy-partner-for-veppanu-vepdegestrant\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Onco360\u00ae Has Been Selected as a National Pharmacy Partner for VEPPANU&#x2122; (vepdegestrant)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Onco360\u00ae Has Been Selected as a National Pharmacy Partner for VEPPANU&#x2122; (vepdegestrant) - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/onco360-has-been-selected-as-a-national-pharmacy-partner-for-veppanu-vepdegestrant\/","og_locale":"en_US","og_type":"article","og_title":"Onco360\u00ae Has Been Selected as a National Pharmacy Partner for VEPPANU&#x2122; (vepdegestrant)","og_description":"LOUISVILLE, Ky., July 29, 2026 (GLOBE NEWSWIRE) &#8212; Onco360\u00ae, the nation\u2019s leading independent Specialty Pharmacy, has been selected as a pharm","og_url":"https:\/\/english.saigonbiz.com\/vn\/onco360-has-been-selected-as-a-national-pharmacy-partner-for-veppanu-vepdegestrant\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2026-07-30T00:05:44+00:00","og_image":[{"width":1074,"height":716,"url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/05\/SaigonBiz-Feature-Image.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/onco360-has-been-selected-as-a-national-pharmacy-partner-for-veppanu-vepdegestrant\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/onco360-has-been-selected-as-a-national-pharmacy-partner-for-veppanu-vepdegestrant\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"Onco360\u00ae Has Been Selected as a National Pharmacy Partner for VEPPANU&#x2122; (vepdegestrant)","datePublished":"2026-07-30T00:05:44+00:00","dateModified":"2026-07-30T00:05:44+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/onco360-has-been-selected-as-a-national-pharmacy-partner-for-veppanu-vepdegestrant\/"},"wordCount":488,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["People"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/onco360-has-been-selected-as-a-national-pharmacy-partner-for-veppanu-vepdegestrant\/","url":"https:\/\/english.saigonbiz.com\/vn\/onco360-has-been-selected-as-a-national-pharmacy-partner-for-veppanu-vepdegestrant\/","name":"Onco360\u00ae Has Been Selected as a National Pharmacy Partner for VEPPANU&#x2122; (vepdegestrant) - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2026-07-30T00:05:44+00:00","dateModified":"2026-07-30T00:05:44+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/onco360-has-been-selected-as-a-national-pharmacy-partner-for-veppanu-vepdegestrant\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/onco360-has-been-selected-as-a-national-pharmacy-partner-for-veppanu-vepdegestrant\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/onco360-has-been-selected-as-a-national-pharmacy-partner-for-veppanu-vepdegestrant\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"Onco360\u00ae Has Been Selected as a National Pharmacy Partner for VEPPANU&#x2122; (vepdegestrant)"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/83269","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=83269"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/83269\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/85254"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=83269"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=83269"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=83269"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}